Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of livestock diseases
3.2.1.2 Growing consumption of meat & dairy products
3.2.1.3 Increased government initiatives and support
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of vaccine development and production
3.2.2.2 Limited access and distribution challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Vaccine Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Inactivated vaccines
5.3 Attenuated/modified live vaccines
5.4 Other vaccine types
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Bovine respiratory diseases (BRD)
6.3 Clostridial diseases
6.4 Bovine viral diarrhea (BVD) infection
6.5 Foot-and-mouth disease (FMD)
6.6 Leptospirosis
6.7 Diarrhea/Scours
6.8 Rift valley fever (RVF)
6.9 Other disease types
Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Cattle
7.3 Sheep & goats
Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Injectable
8.3 Intranasal
Chapter 9 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Veterinary hospitals & clinics
9.3 Livestock farms
9.4 Research institutes
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Bimeda Biologicals
11.2 Boehringer Ingelheim International GmbH
11.3 Ceva Santé Animale
11.4 CZ Vaccines S.A.U. (Zendal Group)
11.5 Elanco Animal Health
11.6 HIPRA
11.7 Indian Immunologicals Ltd.
11.8 Kyoto Biken Laboratories, Inc.
11.9 Merck & Co., Inc.
11.10 Vaxxinova International BV
11.11 Virbac
11.12 Zoetis, Inc.
